Cabozantinib: A Powerful Treatment for Kidney and Thyroid Cancer You Should Know About
Cabozantinib is a well-known cancer medicine used to treat several types of cancers, especially kidney cancer (renal cell carcinoma) and thyroid cancer. It is available in different brands and strengths, including Cabanib 20, Caboxen 20, Caboxen 80, Cabozanix 20, Cabozanix 60, and Cabozanix 80 mg, all of which are available on UnitPharmacy.com.
This medicine works by blocking certain proteins (called tyrosine kinases) that help cancer cells grow and spread. By stopping these proteins, Cabozantinib helps slow or stop the growth of cancer. It is especially effective for people with advanced kidney cancer, medullary thyroid cancer, and liver cancer that has already been treated with other drugs like sorafenib.
Whether you're a patient, caregiver, or healthcare provider, it's important to understand how Cabozantinib works, who it helps, and what the latest research says.
Why Patients Use Cabozantinib
Doctors recommend Cabozantinib (known as Cabometyx in tablets and Cometriq in capsules) because it targets multiple cancer-causing pathways at once. Studies show that it not only helps shrink tumors but also increases survival time in people with renal cell carcinoma and neuroendocrine thyroid tumors.
Cabozantinib is a targeted cancer medicine. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs). These drugs work by blocking specific proteins (enzymes) that cancer cells use to grow and spread.
Cabozantinib is available in two main forms:
Cometriq (capsule) – approved for medullary thyroid cancer
Cabometyx (tablet) – approved for:
Renal Cell Carcinoma (RCC) – advanced kidney cancer
Hepatocellular Carcinoma (HCC) – liver cancer after sorafenib treatment
Differentiated Thyroid Carcinoma – when not responding to radioactive iodine or VEGFR-targeted therapy
At Unit Pharmacy, we offer high-quality Cabozantinib alternatives such as Cabanib, Caboxen, and Cabozanix, in multiple strengths, helping patients worldwide afford their treatment.
How Does Cabozantinib Help Cancer Patients?
Cabozantinib blocks several pathways (including MET, VEGFR, AXL) involved in cancer cell growth, blood vessel formation, and cancer spread. Because it targets multiple pathways, it can stop tumor growth more effectively than drugs that block only one.
✅ In Kidney Cancer (RCC):
Cabozantinib is one of the first-line treatments, especially when combined with another immunotherapy drug called nivolumab. Clinical studies show that this combo can significantly slow disease progression and increase overall survival.
Cabozantinib is highly effective for medullary thyroid cancer and differentiated thyroid cancer that no longer responds to radioactive iodine. For many patients with aggressive or metastatic thyroid cancer, this drug offers a new chance for longer, better-quality life.
Patients who have already tried sorafenib but saw limited success can benefit from Cabozantinib. It has been approved for use in this case based on survival benefits shown in clinical trials.
Cabozantinib Products Available at UnitPharmacy.com
We provide several options to suit different dosage needs:
These products are manufactured by trusted pharmaceutical companies and are available for international shipping. Whether you are from the USA, Australia, Germany, Saudi Arabia, or any other country, you can order directly through our secure website.
Common Side Effects of Cabozantinib
While Cabozantinib is effective, like all strong cancer drugs, it may cause side effects. The most common include:
Hand-foot syndrome (redness/swelling of hands and feet)
These side effects can vary in intensity. Most are manageable with supportive care or dose adjustments. It's important to use Cabozantinib under the care of an oncologist who can monitor your health and manage side effects.
Recent Research and Clinical Trials Brings Hope
Cabozantinib has been a subject of many recent clinical trials. Here are some key highlights:
CheckMate 9ER Trial: A major study showed that Cabozantinib + Nivolumab is better than sunitinib alone for newly diagnosed advanced kidney cancer. Patients had longer progression-free survival and better response rates.
COSMIC-311 Study: For radioactive iodine-refractory thyroid cancer, Cabozantinib showed strong tumor shrinkage and extended disease control compared to placebo.
Combination Therapy Potential: Researchers are now testing Cabozantinib in combination with other drugs, including immune checkpoint inhibitors, to treat neuroendocrine tumors and prostate cancer.
These findings make Cabozantinib one of the most promising multi-target cancer therapies available today.
Why Choose UnitPharmacy.com?
At Unit Pharmacy, we focus on affordable, authentic oncology medicine with a mission to help patients around the world. With over 10 months of trusted service and satisfied customers from Germany, Australia, Saudi Arabia, the USA, and Greece, we’re growing fast — and ready to serve you.
Caboxen 20 mg, Caboxen 80 mg
Cabozanix 20 mg, Cabozanix 60 mg, Cabozanix 80 mg
Browse our secure website UnitPharmacy.com, chat with our support team, and get fast worldwide delivery.
Cabozantinib is helping cancer patients live longer, better lives. With more research showing its success in kidney, thyroid, and liver cancers, it has become a trusted name in cancer care.
If you or a loved one needs this medicine, visit UnitPharmacy.com or Cabozantinib today to explore options like Cabanib, Caboxen, and Cabozanix — all available at affordable prices, delivered with care.
